CCCC Stock Summary and Trading Ideas (C4 Therapeutics | NASDAQ:CCCC)

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

C4 Therapeutics trades on the NASDAQ stock market under the symbol CCCC.

As of November 6, 2026, CCCC stock price climbed to $3.10 with 2,743,779 million shares trading.

CCCC has a beta of 2.16, meaning it tends to be more sensitive to market movements. CCCC has a correlation of 0.14 to the broad based SPY ETF.

CCCC has a market cap of $381.38 million. This is considered a Small Cap stock.

Last quarter C4 Therapeutics reported $8 million in Revenue and -$.16 earnings per share. This fell short of revenue expectation by $-131,712 and exceeded earnings estimates by $.05.

In the last 3 years, CCCC traded as high as $11.88 and as low as $1.06.

The top ETF exchange traded funds that CCCC belongs to (by Net Assets): VTI, IWM, VXF, FESM, IWN.

CCCC has outperformed the market in the last year with a price return of +30.8% while the SPY ETF gained +9.6%. However, in the short term, CCCC had mixed performance relative to the market. It has underperformed in the last 3 months, returning -14.4% vs -4.2% return in SPY. But in the last 2 weeks, CCCC shares have fared better than the market returning -2.5% compared to SPY -3.8%.

CCCC support price is $2.80 and resistance is $3.10 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CCCC shares will trade within this expected range on the day.